Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
1.235
+0.085 (7.39%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Zura Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22 Mar '22
Net Income
-52.4-60.36-28.08-46.91
Depreciation & Amortization
0.01---
Asset Writedown & Restructuring Costs
-27.3823.88-
Stock-Based Compensation
16.89.660.36-
Other Operating Activities
5.213.15-1.3445
Change in Accounts Payable
4.215.944.090.23
Change in Other Net Operating Assets
-1.91-0.83-0.23-
Operating Cash Flow
-28.08-15.05-1.31-1.68
Capital Expenditures
-0.08---
Sale (Purchase) of Intangibles
-5-8-13.09-30
Investing Cash Flow
-5.08-8-13.09-30
Total Debt Issued
--8.29-
Short-Term Debt Repaid
--10--
Total Debt Repaid
--10--
Net Debt Issued (Repaid)
--108.29-
Issuance of Common Stock
68.16120.61--
Repurchase of Common Stock
-0.32---
Other Financing Activities
4210.69-3.09-
Financing Cash Flow
109.84121.2916.1160
Net Cash Flow
76.6998.241.7128.32
Free Cash Flow
-28.15-15.05-1.31-1.68
Free Cash Flow Per Share
-0.38-0.46-5.75-
Levered Free Cash Flow
-24.76-25.08--
Unlevered Free Cash Flow
-24.76-25.08--
Change in Net Working Capital
2-12.41--
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q